Clinical Trials Directory

Trials / Completed

CompletedNCT06576336

A Randomized Clinical Trial About Use of 3D Laparoscopy Versus 2D Laparoscopy in Adrenal Surgery

3D is Better for Adrenal: a Randomized Clinical Trial About Use of 3D Laparoscopy Versus 2D Laparoscopy in Adrenal Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
350 (actual)
Sponsor
University of Palermo · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Comparison between 2D traditional laparoscopic surgery and 3D laparoscopy for adrenal surgery.

Detailed description

Laparoscopic adrenalectomy is today considered the gold standard of treatment for adrenal tumors. This technique was described for the first time by Gagner in 1992 and in the past years several studies have shown the advantages of laparoscopic approach with decrease of the perioperative morbidity, lower complication rates, less operative blood loss, less postoperative pain and shorter hospital stay compared with open adrenalectomy. Laparoscopic surgery is more difficult to learn and requires different psychomotor skills than open laparotomy. In fact, the surgeons have to work in a three-dimensional space, but are guided by two-dimensional images. The development of high definition cameras does not eliminate the major limitation of two-dimensional (2D) laparoscopy: lack of depth perception and lose of spatial orientation with potential increasing the strain for the surgeon, the risk of errors and the operative time. Three-dimensional (3D) HD laparoscopy was developed as an alternative to conventional 2D laparoscopy. In literature there are still few clinical studies on use of 3D in laparoscopic adrenalectomies with different results. For these reasons the investigators propose an international multicenter study to compare 3D laparoscopic adrenalectomy with standard laparoscopic adrenalectomy.

Conditions

Interventions

TypeNameDescription
PROCEDURElaparoscopic adrenalectomylaparoscopic adrenalectomy

Timeline

Start date
2018-01-01
Primary completion
2023-12-31
Completion
2024-06-30
First posted
2024-08-28
Last updated
2024-08-28

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06576336. Inclusion in this directory is not an endorsement.